Research ArticleArticle
A 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy of Oral SCIO-469, a p38 Mitogen-activated Protein Kinase Inhibitor, in Patients with Active Rheumatoid Arthritis
MARK C. GENOVESE, STANLEY B. COHEN, DAVID WOFSY, MICHAEL E. WEINBLATT, GARY S. FIRESTEIN, ERNEST BRAHN, VIBEKE STRAND, DANIEL G. BAKER and SANDRA E. TONG
The Journal of Rheumatology May 2011, 38 (5) 846-854; DOI: https://doi.org/10.3899/jrheum.100602
MARK C. GENOVESE
STANLEY B. COHEN
DAVID WOFSY
MICHAEL E. WEINBLATT
GARY S. FIRESTEIN
ERNEST BRAHN
VIBEKE STRAND
DANIEL G. BAKER
REFERENCES
- 1.↵
- 2.↵Enbrel: Package insert. Thousand Oaks, CA: Immunex; 2006.
- 3.↵Humira: Package insert. Abbott Park, IL: Abbott Laboratories; 2006.
- 4.↵Remicade: Package insert. Malvern, PA: Centocor Inc.; 2007.
- 5.↵
- 6.↵
- 7.↵
- Schett G,
- Tohidast-Akrad M,
- Smolen JS,
- Schmid BJ,
- Steiner CW,
- Bitzan P,
- et al.
- 8.↵
- Thalhamer T,
- McGrath MA,
- Harnett MM
- 9.↵
- 10.↵
- Amakye D,
- Tong S,
- Ward C,
- Beazley W
- 11.↵
- 12.↵
- 13.↵
- 14.↵
- Cohen SB,
- Cheng TT,
- Chindalore V,
- Damjanov N,
- Burgos-Vargas R,
- Delora P,
- et al.
- 15.↵
- 16.↵
- 17.↵
- Kelly J
- 18.↵
- Hammaker D,
- Sweeney S,
- Firestein GS
- 19.↵
- 20.↵
- 21.↵
- 22.↵
- 23.↵
- Kremer JM,
- Bloom BJ,
- Breedveld FC,
- Coombs JH,
- Fletcher MP,
- Gruben D,
- et al.
In this issue
The Journal of Rheumatology
Vol. 38, Issue 5
1 May 2011
A 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy of Oral SCIO-469, a p38 Mitogen-activated Protein Kinase Inhibitor, in Patients with Active Rheumatoid Arthritis
MARK C. GENOVESE, STANLEY B. COHEN, DAVID WOFSY, MICHAEL E. WEINBLATT, GARY S. FIRESTEIN, ERNEST BRAHN, VIBEKE STRAND, DANIEL G. BAKER, SANDRA E. TONG
The Journal of Rheumatology May 2011, 38 (5) 846-854; DOI: 10.3899/jrheum.100602
A 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy of Oral SCIO-469, a p38 Mitogen-activated Protein Kinase Inhibitor, in Patients with Active Rheumatoid Arthritis
MARK C. GENOVESE, STANLEY B. COHEN, DAVID WOFSY, MICHAEL E. WEINBLATT, GARY S. FIRESTEIN, ERNEST BRAHN, VIBEKE STRAND, DANIEL G. BAKER, SANDRA E. TONG
The Journal of Rheumatology May 2011, 38 (5) 846-854; DOI: 10.3899/jrheum.100602